2nd DECENTRALIZED & HYBRID CLINICAL TRIALS WORLD CONGRESS 2026 EUROPE
Patient-centric approach to Decentralized & Hybrid Trials: Understanding the changing landscape, the trends, challenges, and opportunities for a successful implementation.
Wednesday 25th - Thursday 26th February 2026
Facilitate Live is very pleased to welcome you to our upcoming 2nd Decentralized & Hybrid Clinical Trials World Congress 2026 Europe.
Decentralized clinical trials (DCTs) are clinical trials that take place outside of traditional clinical trial sites. They can include activities at a participant’s home, a local health care facility, or a nearby laboratory versus requiring the patient to come to the major clinical facility of the lead researcher. This is made possible through virtual collaboration between the lead researcher and local medical teams, enabled by technology such as apps, electronic monitoring devices, telemedicine and video consultations, and facilitated and monitored through home visits. In addition, researchers can recruit participants from diverse backgrounds and obtain real-world data more quickly and cost-effectively.
A decentralized or virtual protocol is a growing innovation in the conduct of clinical trials. DCTs allow patients to choose how and where they take part in the study, which can be especially beneficial for patients with rare diseases or reduced mobility. Other benefits of DCTs includes less friction in accessing healthcare, more potential for health equity and inclusion in clinical trials, improved patient recruitment and retention, greater potential for the conduct of trials in low prevalence diseases, shorter study timelines, accelerated delivery of new treatments, and improved data quality and accuracy, and ultimately, lower healthcare costs to society.
However, Decentralized clinical trials (DCTs) have several potential issues. DCT designs need to consider how much data to collect and how to store and process it. Data quality may be compromised due to the diverse technologies being used which may introduce variability in data quality. There’s a higher risk that patients could use a device incorrectly or record data incorrectly. Researchers should make the process for study consent and withdrawal as user- friendly as possible. The need for vigorous data security and privacy solutions to safeguard sensitive information. Managing participant safety is a factor that trial leaders must also address. There is the risk of technological failure, which could lead to a loss of patient data. DCTs need to comply with regulations. Another issue with DCTs is, some patients may be more comfortable being seen in person, especially if they are unsure about using technology or administering tests.
The upcoming Decentalized & Hybrid Clinical Trials World Congress Europe aims to bring together stakeholders to discuss strategies and best practices, innovations, technologies and concepts that addresses the issues surrounding DCTs, in a dynamic interactive, thought-provoking and uplifting manner.
We look forward to welcoming you to the Decentralized & Hybrid Clinical Trials World Congress 2026 Europe.
Sincerely yours,
Jocelyn Raguindin
Conference Director
Facilitate Live
Gain The Latest Insights On:
- Identify barriers in decentralized research implementation and create tools to overcome them
- How to enhanced patients or participants experience
- Addressing obstacles in communication, productivity, and adoption.
- Understanding the DCT regulatory guidelines
- Assessing the impact of decentralized elements on patient safety
- Strategies to be put in place to reduce potential errors that could compromise data integrity
- Approaches to establish a patient- centric middle ground
- Initiatives to ensure the success and growth of decentralized clinical trials.
- Intensify your study impact by using state of the art technologies and solutions that broadens clinical trial participant diversity, equity and inclusion
- Key milestones that are integral to successful planning and execution
- Network with leaders shaping the future of clinical trials for operational insights, ethical guidance, and industry collaboration on Hybrid & Full DCTs
Sponsorship & Exhibit Opportunities
Our event partners and team of experts are recognized for creating and providing unique, innovative events. We open doors and create access to business opportunities for our clients. Our events are forum for discussion, learning, showcasing new technologies, innovations, new products and trends, solutions and concepts.
The impact you make and how you get your message across at our Facilitate Live Events is up to you – we offer packages or tailor made solutions to meet your exact requirements and budget.
By sponsoring a Facilitate Live Event you will be exposed to the following:
- Access to key decision makers
- Direct access to our delegates and attendees
- Increase worldwide awareness of your organisations latest products and services
- Drive and create new business opportunities
- Generate new contacts and renewed interest for your product of expertise
- Be recognised as a key player and a key supporter of your industry sector
- Demonstrate your organization’s commitment
- Demonstrate your excellence as a technical supplier
- Show brand awareness and brand building
- Brand and product endorsements
- Extensive pre-show and post-show coverage
Solution Showcase
Showcase your latest cutting-edge solutions, new products, technology, innovations and trend. Meet face to face with high level decision makers who are in a receptive mindset and actively seeking solutions and services.
As an exhibitor you will gain access to this exclusive captive audience and have the opportunity to:
- Speak to the attendees and demonstrate your product / services at the solution showcase network to captive and receptive key decision makers
- Gain exposure to one of our Facilitate Live
- Host a networking drinks reception or lunch for attendees
- Meet one-on-one with attendees
- Generate a high number of leads with senior decision makers
- Meet your peers and exhibit alongside your competitors
- Present case studies and in-depth information in a solution provider showcase session
- Present case studies and in-depth information in a solution provider showcase session
- Educate the market with your product and technology solutions
Sponsorship & Exhibit Inquiries
Email: Sponsor@facilitatelive.com  Tel No: +44 (0)207 193 3485
Who Should Attend:
This Congress will provide information to pharmaceutical and biotech companies, researchers, physicians, institutional review boards (IRBs), patient organizations and advocates, and regulatory agencies about the implementation of Real-World Evidence.Â
Network with members of the boards, VP’s, Directors, Heads/Chiefs, and Senior Managers of leading Pharmaceuticals and Biotech Companies, Government, CRO’s and Solution Providers Involved in:
- Decentralized Clinical Trials Operations
- Hybrid Trials
- Clinical Data Management
- Clinical Development & Operations
- Clinical Trial Tools & Technologies
- Clinical Strategy
- Patient Engagement
- Data Management
- Digital Health Process & Solution
- Clinical Research
- Statistical Scientist
- Regulatory Affairs
- Clinical Studies
- Clinical Operations
- Clinical Trial Site
- Trial Designs
- Patient Advocacy
- Consultant
- Clinical Research
- Global Development Solutions
- Electronic Clinical Outcome Assessment (eCOA)
- Contract Research Organizations
- Medical Affairs, Global Patient Advocacy & Alliances
- Government Policy and Advocacy
- Digital Patient Experience Lead
- Clinical Insights and Experience
- Head of Strategy, Access Services
- Product Lifecycle
- Patient and Disease Registries
- Scientific Affairs
- Electronic & Medical Records
- Lab & Biomarkers
- Medical and Pharmacy data
- Clinical Supply Chain Management
- Digital Strategy and Engagement
- Patient Recruitment and Retention
- AcademiaÂ
- And much more…
Co-located with Patient Centricity & Collaboration World Congress 2026 Europe.Â
Joint Networking & Exhibit Area.Â
Website: www.patientcentricityworld.com
REGULATORY GUIDELINES
- Addressing varying regulatory guidelines for DCT
- Emerging regulatory frameworks and approaches
- Potential opportunities and challenges for DCT solution providers.
- Regulations clarifying access to health technologies and technical requirements.
- Adhering with data privacy laws and compliance
- Lessons learned and future of DCTs
Moderator:
Panelist:
- Brief overview of the current guidelines
- ACT EU Pilot scheme for trials with decentralized elements
- Harmonised and transparent approach for the use of DCT elements in clinical trials.
- Review outlines of gap analysis focused on the frameworks and guidance
- The need for a comprehensive sustainability assessment of each DCT element
- Guidance related to a comprehensive assessment of designing and executing sustainable DCTs needed
- Factors stakeholders regard as having the most significant impact on driving sustainability decisions in DCTs.
CURRENT TRENDS AND STRATEGIES
- Current role of digital platforms in supporting decentralized trial activities
- Challenges and benefits of digital platforms to investigators and participants
- The obstacles developers must address before a fully integrated and unified DCT can be realized.
- New tools and framework that facilitates progressive decentralization
- Technological developments in telehealth
- Important aspects to consider when conceptualizing a phase 1 decentralized clinical trial
- Examples of promising model for early drug development.
- Current adoption of remote monitoring and data collection technologies
- Drivers of increasing adoption of remote monitoring and data collection technologies
- Remote monitoring and data collection technologies with greatest outcomes associated with patient experience
- Aspirations and direction for industry to enable more patient-centric trials.
- Ethical aspects of digitalization in clinical trials associated with digital technologies
- Informed consent in clinical research
- Decentralized informed consent procedures that are impacted by digitalization
- Electronic consenting technologies and procedures
- Opportunities and Considerations
- Data-Driven Solutions in Planning and Feasibility of Clinical Trials
- Various decentralization components available for stakeholders to increase the reach and pace of their trials
- Fit-for-Purpose, Usability Studies, and Contingencies
- Examples of trials with dual DCT and DHT components
- What is IRT and why use it for your trial?
- Greatest challenges and obstacles to consider when selecting new IRT innovations?
- Technical and operational considerations in selecting an IRT vendor
- What are the benefits to look for?
- Perspectives and guidance for effective eCOA in global DCTs
- Preparations to implement eCOA in your global DCTs
- What are the complexities of the eCOA process
- Can technology play a pivotal role in achieving better outcomes?
- Benefits of Decentralized Clinical Trials revolutionizing the way research is conducted
- Key Components of Decentralized Trials reshaping the traditional model
- Ethical standards and participant safety as crucial cornerstones of the research effort
- Challenges and barriers in clinical research
- Principles for successful Decentralization in Clinical Trials
PATIENT ENGAGEMENT & COLLABORATIONS
- Transformative potential of decentralized clinical trials in addressing the limitations of traditional randomized controlled trials
- Utilizing remote digital technologies and community providers to enable broader, more inclusive participation
- Potential of DCTs for democratizing clinical research
- Research needed to devise standardized protocols to streamline DCT processes, explore its long-term
impacts on patient outcomes, and overcome challenges through equitable stakeholder engagement.
- The aim of decentralised trials in patient centricity, enhanced efficacy in clinical trial conduct and generating real-world data
- Finding what is a true patient-centric approach and understanding what patients really want
- Incorporating patient voice in designing clinical trials
- How does DCT and Hybrid trials overcome hurdles in recruitment and retention
- Key elements that need to be in place in a DCT setting to ensure good levels of patient retention.
- Incorporating DCT elements into hybrid models
- Explore the role of DCTs in offering flexible options for the patient
- Addressing disparity in clinical trial representation
- Opportunities for DCT approaches to improve inclusivity
- Challenges and opportunities for researchers to adopt and adapt DCT approaches
- Factors enhancing the inclusion of marginalized and vulnerable populations in trials
- Clinical trial strategy planning in the new era of digital health
- Cost drivers of potential cost savings
- Sponsor cost and budget considerations
- Budget trends in DCTs and virtual clinical trials
- Importance of strong relationship with sit and site network critical to the success of clinical trials
- Strategies sponsors can develop to build strong site relationships at scale.
- Key factors that are highly valued by both Contract Research Organisations (CROs) and Sponsors.
- Future directions for improving relationships with sites and site networks.
The Future of Real-World Evidence
- Remote method of trial delivery
- Open access toolkit of resources and guidance for researchers to support the transition to remote delivery
- Expanding UK capabilities in decentralized trial delivery
- Decentralized clinical trials: case studies
- Addressing structural barriers and how we get improved access to clinical trials
- Impact of incorporating decentralized elements into clinical trials on data integrity, patient safety, and regulatory approvals.
- Additional initiatives aiming to extend access and inclusion in clinical trials
- Fostering partnerships to increase patient and local clinician access to the clinical trials
- Practical applications of how to implement meaningful and consistent Patient Engagement
- The value of co-creating a clinical outcome assessment strategy for clinical trial research
- Next step toward delivering the best possible research experience for patients by co-creating studies with patients.
- Challenges facing the adoption of decentralized trials
- Approaches for decentralized trials as well as key performance indicators
- Best practices that reduce risk and improve the execution of decentralized clinical trials
- Availability of educational resources for all stakeholders and advance a supportive culture and environment to increase uptake of decentralized research
- Recognise remaining barriers to the global conduct of decentralized trials and map route to resolution
Moderator:
Panelists: